MIOSHA Part 554 Bloodborne Infectious Diseases Train the Trainer Program Module 2 - PowerPoint PPT Presentation

About This Presentation
Title:

MIOSHA Part 554 Bloodborne Infectious Diseases Train the Trainer Program Module 2

Description:

Rule 13 Vaccinations and postexposure follow-up ... still non-responder, follow CDC guidelines as ... Follow-up procedures. Signs and labels or color coding ... – PowerPoint PPT presentation

Number of Views:144
Avg rating:3.0/5.0
Slides: 35
Provided by: MIO4
Learn more at: https://www.michigan.gov
Category:

less

Transcript and Presenter's Notes

Title: MIOSHA Part 554 Bloodborne Infectious Diseases Train the Trainer Program Module 2


1
MIOSHAPart 554 Bloodborne Infectious
DiseasesTrain the Trainer ProgramModule 2
  • Presented By
  • Consultation Education Training (CET) Division
  • Michigan Occupational Safety Health
    Administration www.michigan.gov/miosha
  • (517) 284-7720

2
Welcome
  • Welcome to the MIOSHA Bloodborne Infectious
    Diseases Online Training Module 2.
  • This is a continuation of the MIOSHA program
    designed to provide an overview of the MIOSHA
    bloodborne standard.
  • It does NOT fullfill all the training
    requirements in the Bloodborne Standard nor is it
    intended to replace facility specific training.

3
Intended Use Train the Trainer
  • Provide bloodborne infectious diseases
    information to those who provide training to
    employees who are at risk of occupational
    exposure.
  • Provide additional resources to assist trainers
    in becoming more knowledgeable in topics related
    to bloodborne infectious diseases.

4
Module 2
  • This is a continuation of the MIOSHA Bloodborne
    Infectious Diseases online training program. This
    module will provide an overview of Rules 10-16.
  • Note Rule 12 covers HIV and HBV research
    laboratories and productions facilities. Due to
    limited application, this rule will not be
    included in this overview.

5
Overview of the Bloodborne Standard
Module 1
Module 2
  • Rule 1 Scope
  • Rule 2 Definitions
  • Rule 3 Exposure determination
  • Rule 4 Exposure control plan
  • Rule 5 Universal precautions
  • Rule 6 Engineering controls
  • Rule 7 Work practices
  • Rule 8 Protective work clothing and equipment
  • Rule 9 Housekeeping
  • Rule 10 Regulated waste
  • Rule 11 Laundry
  • Rule 12 HIV and HBV research laboratories and
    production facilities
  • Rule 13 Vaccinations and postexposure follow-up
  • Rule 14 Communication of hazards to employees
  • Rule 15 Recordkeeping
  • Rule 16 Information and training
  • Appendices

6
Rule 10 Regulated Waste Disposal
  • Regulated Waste shall be placed into containers
    or bags that are
  • Closable
  • Leakproof
  • Color-coded or labeled
  • For contaminated sharps all the above plus
    puncture-resistant

7
Rule 11 Laundry
  • Minimize agitation
  • Bag at the location where it is generated
  • Color-coded bags or containers

8
  • The next slide will provide questions to assist
    with reviewing the Bloodborne Infectious Diseases
    Standard
  • Rule 10 Regulated Waste
  • Rule 11 Laundry

9
Rule 10-11 Waste and LaundryQuestions and
Answers
Questions and answers will appear below. There
will be delays to allow time to answer the
questions.
  • True or False
  • This container is acceptable for disposal of
    contaminated sharps
  • False. Improper label and/or color.
  • See Rule 10 (2)
  • Employees may launder their contaminated work
    clothes at home.
  • False. Rule 11 (5) states that the employer is
    responsible to laundry contaminated clothing.

Detergent
10
Rule 13 Vaccinations and postexposure follow-up
  • Performed by a licensed health care professional
  • Provided at no cost by the employer
  • Provided according to U.S. public health service
    (Centers for Disease Control and Prevention).
  • Counseling

11
Rule 13 Vaccinations and postexposure follow-up
Continued
  • Hepatitis B Vaccine
  • Offered within 10 days
  • HBV antibody testing offered after new employee
    vaccination
  • Employees may decline the series

Note Clarification related to offering the HBV
vaccination to 1st Aid providers is available
through a Federal OSHA letter of interpretation
(External link)
12
HBV Antibody Testing
  • According to Current CDC recommendations
    healthcare workers (new employees)
  • Must offer antibody titre within 60 days of the
    last vaccine in series.
  • If not responder, offer series of 3 again and
    titre as described above.
  • If still non-responder, follow CDC guidelines as
    appropriate.
  • Guidelines for the Management of Occupational
    Exposures to HBV, HCV, and HIV and
    Recommendations for Postexposure Prophylaxis
    (External link)

13
  • The next slide will provide questions to assist
    with reviewing the Bloodborne Infectious Diseases
    Standard
  • Rule 13 Vaccinations and postexposure follow-up

14
Rule 13 HBV Vaccination and TitreQuestions and
Answers
Questions and answers will appear below. There
will be delays to allow time to answer the
questions.
  • True or False. Antibody testing is to be offered
    to new employees who accept the HBV vaccine
    within 30-60 days following administration of the
    HBV vaccination series.
  • True. Rule 13(2) states that an employer shall
    provide according to the current recommendations
    of the U.S. public health service CDC.
  • Note Current CDC recommendations can be found
    in the Guidelines for the Management of
    Occupational Exposures to HBV, HCV, and HIV and
    Recommendations for Postexposure Prophylaxis
    (External link)

15
Rule 13 Vaccinations and postexposure follow-up
Continued
  • Medical Evaluation
  • Confidential
  • Route of exposure (i.e. needlestick, splash to
    eyes, etc.)
  • Source individual identification and testing
  • Exposed individual blood testing
  • Postexposure prophylaxis as recommended by U.S.
    public health service (CDC)
  • Counseling
  • Evaluation of illnesses

16
Rule 13 Vaccinations and postexposure follow-up
Continued
  • Updated U.S. Public Health Service Guidelines for
    the Management of Occupational Exposures to HBV,
    HCV and HIV and Recommendations for Postexposure
    Prophylaxis
  • Guidelines for the Management of Occupational
    Exposures to HBV, HCV, and HIV and
    Recommendations for Postexposure Prophylaxis
    (External link)

17
Rule 13 Vaccinations and postexposure follow-up
Continued
  • Employers shall provide to health care
    professionals a copy of the BID Rules and
    appendices

18
Rule 13 Vaccinations and postexposure follow-up
Continued
  • Employers shall ensure that health care
    professionals who evaluate employees after an
    exposure have been given the following
    information
  • Description of employees duties as related to the
    exposure incident
  • Documentation of the route and circumstances
    surrounding the exposure
  • Results of the source individuals blood testing
  • Relevant medical records (including vaccine)
  • Description of PPE used or to be used

19
Rule 13 Vaccinations and postexposure follow-up
Continued
  • Employer shall obtain and provide to exposed
    employee a copy of the health care professionals
    written opinion limited to
  • HBV vaccine information
  • Statement that employee has been informed of test
    results and medical conditions that may have
    resulted from exposure

20
  • The next slide will provide questions to assist
    with reviewing the Bloodborne Infectious Diseases
    Standard
  • Rule 13 Vaccinations and postexposure follow-up

21
Rule 13 Post-exposure Follow-upQuestions and
Answers
Questions and answers will appear below. There
will be delays to allow time to answer the
questions.
  • True or False
  • Employee medical evaluations and test results are
    confidential.
  • True. Rule 13 (5)
  • Employers have the right to know the HIV status
    of their employees.
  • False. Rule 13 (7) (b) states that the employer
    has the right to receive a statement that
    employee has been informed of test results and
    medical conditions that may have resulted from
    exposure

22
Rule 14 Communication of Hazards to Employees
  • Signs posted in work areas
  • Labels affixed to containers of blood or OPIM

23
Rule 15 Recordkeeping
  • Employer shall establish and maintain medical
    records for each category A employee for duration
    of employment plus 30 years.
  • Training records shall be maintained for 3 years

24
Rule 15 Recordkeeping Continued
  • Sharps Injury Log for contaminated sharps
    injuries must contain
  • Type and brand of device
  • Work unit or area where the incident occurred
  • Explanation of how it happened
  • Must protect employee confidentiality
  • Applies to employers required to maintain a log
    under Part 11 Recording and Reporting of
    Occupational Injuries and Illnesses

Note Employers are permitted to use the 300 Log
to record sharps injuries and are encouraged to
use separate page(s) of the log just for
recording sharps injuries.
25
  • The next slide will provide questions to assist
    with reviewing the Bloodborne Infectious Diseases
    Standard
  • Rule 14 Communication of hazards to employees
  • Rule 15 Recordkeeping

26
Rule 15 RecordkeepingQuestions and Answers
Questions and answers will appear below. There
will be delays to allow time to answer the
questions.
  • True or False
  • Employee medical records shall be kept for 5
    years.
  • False. Rule 15 (4) states that an employer shall
    establish and maintain medical records for each
    employee for duration of employment plus 30
    years.
  • Employers shall establish and maintain a log of
    contaminated sharps injuries.
  • True. Rule 12 (A) Note Exception described in
    Rule 12 (b) and (c) .

27
Rule 16 Information and Training
  • Required for all category A employees
  • At no cost
  • During work hours
  • At the time of initial assignment
  • Annual refresher
  • Appropriate for the educational level, literacy,
    and language of employees

28
Rule 16 Information and Training Continued
  • Contents of the training program
  • Accessibility and explanation of the BID Rules
  • Epidemiology and symptoms of bloodborne diseases
  • Modes of BID transmission
  • Exposure Control Plan with SOPs
  • Methods for recognizing tasks and procedures that
    involve exposure to blood or OPIM

29
Rule 16 Informationand Training Continued
  • Contents of the training program (continued)
  • Use and limitations of
  • Engineering controls
  • Work Practices
  • PPE
  • PPE selection criteria
  • Hepatitis B vaccine including availability,
    efficacy, benefits and no cost

30
Rule 16 Informationand Training Continued
  • Contents of the training program (continued)
  • What actions to take in case of an emergency
    involving blood or OPIM
  • Follow-up procedures
  • Signs and labels or color coding

31
  • The next slide will provide questions to assist
    with reviewing the Bloodborne Infectious Diseases
    Standard
  • Rule 16 Information and training

32
Rule 16 Information and TrainingQuestions and
Answers
Questions and answers will appear below. There
will be delays to allow time to answer the
questions.
  • True or False
  • Training is required for Category A employees
    initially and at least annually.
  • True. Rule 16 (2).
  • This MIOSHA training program meets all the
    employee training provisions.
  • False. Refer to Rule 16 (5) (a)-(l) for all the
    required training elements.

33
Contact MIOSHA for Additional Information
  • Questions www.michigan.gov/askmiosha
  • Consultation Education and Training Division
    (517) 284-7720
  • General Industry Safety and Health Division
    (Compliance) (517) 284-7750
  • Link to additional online resources.
  • Return to the MIOSHA homepage.

34
Thank you for participating
  • This completes the overview of the MIOSHA
    Bloodborne Infectious Diseases Standard.
Write a Comment
User Comments (0)
About PowerShow.com